Lelou E, Rauch C, Dubois-Pot-Schneider H, Dufresne M, Zekri Yazdi A, Guillout M, Cano L, Desquilles L, Nesseler N, Bourgeois M, Bendavid C, Massart J, Musso O, Corlu A, Aninat C

Liver Int. 2026 08;46(8):e70775

Nuclear and membrane-bound hormone receptors in glioblastoma: Expression, functionality, and therapeutic implications.

Gantner A, Dubois-Pot-Schneider H, Dumond H

Neurooncol Adv. 2025 12 9;8(1):vdaf252

Estrogen signaling in healthy and tumor brain.

Hirtz A, Rech F, Dubois-Pot-Schneider H, Dumond H

Steroids. 2023 08 3;:109285

Transcriptomic Study on Human Skin Samples: Identification of Two Subclasses of Actinic Keratoses.

Dubois-Pot-Schneider H, Khairallah G, Brzenczek C, Plénat F, Marchal F, Amouroux M

Int J Mol Sci. 2023 03 21;24(6):

Molecular Characterization of the Dual Effect of the GPER Agonist G-1 in Glioblastoma.

Hirtz A, Bailly Y, Rech F, Pierson J, Dumond H, Dubois-Pot-Schneider H

Int J Mol Sci. 2022 11 18;23(22):

Identification of Gender- and Subtype-Specific Gene Expression Associated with Patient Survival in Low-Grade and Anaplastic Glioma in Connection with Steroid Signaling.

Hirtz A, Lebourdais N, Thomassin M, Rech F, Dumond H, Dubois-Pot-Schneider H

Cancers (Basel). 2022 08 25;14(17):

Transcriptional and Epigenetic Consequences of DMSO Treatment on HepaRG Cells.

Dubois-Pot-Schneider H, Aninat C, Kattler K, Fekir K, Jarnouen K, Cerec V, Glaise D, Salhab A, Gasparoni G, Takashi K, Ishida S, Walter J, Corlu A

Cells. 2022 07 26;11(15):

GPER Agonist G-1 Disrupts Tubulin Dynamics and Potentiates Temozolomide to Impair Glioblastoma Cell Proliferation.

Hirtz A, Lebourdais N, Rech F, Bailly Y, Vaginay A, Smaïl-Tabbone M, Dubois-Pot-Schneider H, Dumond H

Cells. 2021 12 7;10(12):

Astrocytoma: A Hormone-Sensitive Tumor?

Hirtz A, Rech F, Dubois-Pot-Schneider H, Dumond H

Int J Mol Sci. 2020 Nov 30;21(23):

Predictive early gene signature during mouse Bhas 42 cell transformation induced by synthetic amorphous silica nanoparticles.

Kirsch A, Dubois-Pot-Schneider H, Fontana C, Schohn H, Gaté L, Guichard Y

Chem. Biol. Interact.. 2019 Nov 15;:108900

Cytochrome P450 1A1/2, 2B6 and 3A4 HepaRG Cell-Based Biosensors to Monitor Hepatocyte Differentiation, Drug Metabolism and Toxicity.

Vlach M, Quesnot N, Dubois-Pot-Schneider H, Ribault C, Verres Y, Petitjean K, Rauch C, Morel F, Robin MA, Corlu A, Loyer P

Sensors (Basel). 2019 May 15;19(10):

A review of post-translational modifications and subcellular localization of Ets transcription factors: possible connection with cancer and involvement in the hypoxic response.

Charlot C, Dubois-Pot H, Serchov T, Tourrette Y, Wasylyk B

Methods Mol Biol. 2010;647:3-30.

The ternary complex factor Net/Elk-3 participates in the transcriptional response to hypoxia and regulates HIF-1 alpha.

Gross C, Dubois-Pot H, Wasylyk B

Oncogene. 2008 Feb 21;27(9):1333-41

Fiche personne Projets Publications

Retrouvez aussi

Personnes

Equipes

Plateformes

Unités de recherche, établissements

Projets de recherche

Publications scientifiques

Dr DUBOIS-POT-SCHNEIDER Hélène

Fiche personne

Coordonnées

Territoire

Statut

Affiliation

Équipes/plateformes

Recherche

Projets

Combinaison d’approches IA, de criblage virtuel et d’analyses fonctionnelles de ligands de GPER pour la validation d’une première thérapie ciblée des glioblastomes (GLIOLIG)

Mécanismes d'action des œstrogènes et progestatifs dans la progression des gliomes de bas grade (Pro-Glio)

Caractérisation moléculaire de lésions précancéreuses de la peau : les Kératoses Actiniques (CaMoKa)

Publications

Catecholamines Activate a Tumour Progression Program in Differentiated Tumour Hepatocytes.